Olmesartan Medoxomil 40mg + Chlorthalidone 12.5mg Tablets

Olmesartan Medoxomil 40mg + Chlorthalidone 12.5mg combines an angiotensin-receptor blocker with a thiazide-like diuretic for high blood pressure. It is used when relaxation of blood vessels and additional salt removal are both needed for control.
Take in the morning, with or without food, to reduce night-time urination. Rise slowly if dizzy. Kidney function, sodium and potassium are monitored because the net electrolyte effect cannot be predicted from the two ingredients alone.
Olmesartan blocks angiotensin II-mediated vessel tightening. Chlorthalidone reduces renal sodium reabsorption, increasing salt and water excretion and contributing to sustained blood-pressure lowering.
Dizziness, increased urination, dehydration and changes in sodium or potassium may occur. Severe weakness, palpitations, fainting or markedly reduced urination needs assessment.
Pregnancy, dehydration and significant kidney dysfunction are important risks. Chlorthalidone can raise uric acid and worsen gout. Lithium and NSAID painkillers can interact. Persistent diarrhoea with weight loss also warrants assessment of olmesartan-related enteropathy.
Combines complementary mechanisms for sustained blood-pressure reduction when one agent is insufficient.
No. Both are diuretics, but their duration, potency and dose ranges differ; they are not milligram-for-milligram substitutes.
Chlorthalidone can reduce uric-acid elimination and provoke gout in susceptible people.
Yes. Olmesartan and the diuretic have different potassium effects, so a blood test determines the actual result.
The noticeable diuretic effect may lessen while the blood-pressure benefit persists.
Fluid loss can increase hypotension and kidney injury risk, sometimes requiring a temporary sick-day treatment plan.
Chlorthalidone: a long-acting thiazide-like diuretic. Electrolytes: minerals such as sodium and potassium. Volume depletion: insufficient circulating fluid. Uric acid: the substance that forms crystals in gout; AR: Olmesartan Medoxomil 40mg + Chlorthalidone 12.5mg أقراص; FR: Olmesartan Medoxomil 40mg + Chlorthalidone 12.5mg comprimés; PT: Olmesartan Medoxomil 40mg + Chlorthalidone 12.5mg comprimidos; ES: Olmesartan Medoxomil 40mg + Chlorthalidone 12.5mg comprimidos; RU: Olmesartan Medoxomil 40mg + Chlorthalidone 12.5mg таблетки; ID: Olmesartan Medoxomil 40mg + Chlorthalidone 12.5mg tablet; VI: Olmesartan Medoxomil 40mg + Chlorthalidone 12.5mg viên nén; MS: Olmesartan Medoxomil 40mg + Chlorthalidone 12.5mg tablet; TL: Olmesartan Medoxomil 40mg + Chlorthalidone 12.5mg tableta; ZH-SG: Olmesartan Medoxomil 40mg + Chlorthalidone 12.5mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Olmesartan Medoxomil 40mg + Chlorthalidone 12.5mg Tablets under Cardiac Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Olmesartan Medoxomil 40mg + Chlorthalidone 12.5mg Tablets